MyBCTeam

Raloxifene (Evista) is one type of Selective Estrogen Receptor Modulator (SERM), but tamoxifen is typically the SERM prescribed for premenopausal women with breast cancer. While raloxifene can be used in breast cancer treatment, it's more commonly prescribed for postmenopausal women. One benefit of raloxifene is that it Show Full Answer

Raloxifene (Evista) is one type of Selective Estrogen Receptor Modulator (SERM), but tamoxifen is typically the SERM prescribed for premenopausal women with breast cancer. While raloxifene can be used in breast cancer treatment, it's more commonly prescribed for postmenopausal women. One benefit of raloxifene is that it doesn't increase the risk of uterine cancer, unlike some other hormone therapies. However, for premenopausal women with breast cancer, tamoxifen remains the standard SERM treatment, typically taken as a daily pill for five years or longer. It would be important to discuss with your oncologist why they might be considering raloxifene in your specific case, as there may be particular factors influencing this choice.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Hormonal Therapy for Breast Cancer

Side Effects of Hormone Treatment for Breast Cancer